Clinical Trials

650 enrolled

HER2-positive Breast Cancer

NCT06062810 2026-03-09

Drugs-SNPs

600 enrolled

Breast Neoplasms

NCT03077841 2026-03-05

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Phase 2/3 Suspended

928 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT04715958 2026-02-17

Prediction of Neoadjuvant Chemotherapy Response Using Contrast-Enhanced Ultrasound in Patients With Locally Advanced Breast Cancer

200 enrolled

Anatomic Stage III Breast Cancer AJCC v8

NCT07373782 2026-01-28

Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer

53 enrolled

Microcephaly, Primary Autosomal Recessive, 6, Breast Neoplasms

NCT07366840 2026-01-26

BRIGHT

268 enrolled

Breast Neoplasms

NCT05860465 2026-01-14

Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer

254 enrolled

Breast Neoplasms

NCT04290793 2026-01-07

Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer

113 enrolled

Breast Neoplasms

NCT07310758 2025-12-30

Contrast-enhanced Ultrasound for Sentinel Node Detection

BreastDermatologicHead & Neck

91 enrolled

Breast Neoplasms, Head and Neck Neoplasms, Melanoma

NCT07294508 2025-12-29

A Study to Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast Cancer

706 enrolled

Breast Neoplasms

NCT07294534 2025-12-19

A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination With HLX22 or Pertuzumab in the Neoadjuvant Therapy of HER2-Positive Bresat Cancer

817 enrolled

Breast Neoplasms

NCT06891833 2025-10-02

A Study of BL-M07D1 With or Without Pertuzumab Versus Taxane + Trastuzumab and Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer

120 enrolled

HER2-positive Breast Cancer

NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

130 enrolled 8 charts

Breast Carcinoma In Situ, Breast Neoplasms

NCT05744687 2025-08-17

Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer

374 enrolled

Breast Neoplasms

NCT06958627 2025-05-06

any

964 enrolled

HER2 Positive Breast Cancer

NCT05288777 2025-04-18

Breast53

45 enrolled

Breast Neoplasms

NCT05555706 2025-04-15

Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

62 enrolled

Triple Negative Breast Neoplasms

NCT01779206 2025-04-08

ADAPT

4,936 enrolled

Breast Neoplasms

NCT06910072 2025-04-04

Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer

32 enrolled

Triple Negative Breast Neoplasms

NCT06769919 2025-01-10

A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer

340 enrolled

Breast Neoplasms

NCT05747794 2024-12-17

AIPAC-003

849 enrolled

Breast Neoplasms

NCT02883361 2024-12-05

MI for AIs

Phase 2/3 Withdrawn

Breast Neoplasms, Medication Adherence

NCT05889390 2024-12-03

NeoHTerMa

71 enrolled

Hyperthermia, Breast Neoplasms

NCT00221221 2024-11-05

Physical Activity Promotion in Breast Cancer Survivors

300 enrolled

Breast Neoplasms, Motor Activity

NCT05426486 2024-10-30

A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients

136 enrolled

HER2-positive Breast Cancer

NCT03315364 2024-07-25

OPTIMAL

549 enrolled

Breast Neoplasms, Recurrence

NCT03500380 2024-02-20

A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases

301 enrolled

Breast Diseases, Breast Neoplasms

NCT02641847 2024-01-25

TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature

503 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05189535 2024-01-23

"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"

66 enrolled

Breast Neoplasms, Peripheral Nervous System Diseases

NCT02068092 2023-10-10

Olive Oil for High Risk Breast Cancer Prevention in Women

51 enrolled 6 charts

Breast Neoplasms

NCT02221999 2023-08-29

SHPD002

250 enrolled

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT03564171 2023-04-12

Prehabilitation for Women Undergoing Pre-operative Chemotherapy for Breast Cancer

63 enrolled

Breast Neoplasms

NCT05804916 2023-04-07

Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer

556 enrolled

Breast Neoplasms

NCT05802342 2023-04-06

A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer

150 enrolled

To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients

NCT03354611 2023-03-16

Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging

Phase 2/3 Terminated

21 enrolled

Breast Neoplasms

NCT04803539 2023-02-21

Artemis

260 enrolled

Breast Neoplasms

NCT04554056 2022-12-02

Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF

586 enrolled

Breast Cancer Female

NCT05103644 2022-11-02

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

60 enrolled

Breast Neoplasms

NCT01057069 2022-10-12

neo-TN

310 enrolled

Breast Neoplasms

NCT05518292 2022-09-28

Comparison of Analgesic Efficacy of Ultrasound Guided Rhomboid Intercostal Block Versus Serratus Anterior Plane Block for Mastectomy Surgery

60 enrolled

Breast Neoplasms

NCT00247975 2022-08-16

Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

Phase 2/3 Terminated

36 enrolled

Breast Neoplasms, Heart Failure

NCT04429893 2022-08-02

Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy

80 enrolled

Breast Neoplasms

NCT03674242 2022-08-01

Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)

Phase 2/3 Terminated

27 enrolled

Triple Negative Breast Neoplasms

NCT05253066 2022-02-23

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

130 enrolled

Breast Neoplasms

NCT05189067 2022-01-12

Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer

190 enrolled

HER2-positive Breast Cancer

NCT02692755 2021-09-28

PALINA

35 enrolled 12 charts

Hormone Receptor Positive HER-2 Negative Breast Cancer

NCT04059809 2021-08-13

Photobiomodulation for Breast Cancer Radiodermatitis

48 enrolled

Breast Neoplasms, Radiation Injuries, Radiodermatitis

NCT04576143 2021-08-12

Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer

260 enrolled

HER2-negative Breast Cancer

NCT00397761 2021-02-17

Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 2/3 Withdrawn